Chemokines in tuberculosis: the good, the bad and the ugly.
about
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyNeutrophils in Tuberculosis: Heterogeneity Shapes the Way?Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses.Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection.Striking the right immunological balance prevents progression of tuberculosis.Vaccine research and development: tuberculosis as a global health threat.Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions.Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.Potential immunological biomarkers for detection of Mycobacterium tuberculosis infection in endemic setting, Ethiopia.Potential Diagnostic Power of Blood Circular RNA Expression in Active Pulmonary Tuberculosis.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.
P2860
Q26775404-26FFD085-DB76-49DA-A5D2-99C1D1336783Q33775674-C496DF89-B055-4985-9DFB-824DB7D1F1A3Q35924945-4B7B6EED-5755-4201-BE65-886618445242Q35950533-BB1F1852-5B02-4C3E-97DE-6244A89419BAQ37435081-5153AE63-CE6C-4F4A-AB17-2C01CD14E387Q38893448-5C7E23AB-7EDC-45F5-8715-F70DD562CAF7Q38936163-267CDB6B-F352-4F70-99EE-1EA3E0DC5893Q39437320-10481B40-0AAE-4BDA-AC94-91FC588D18BDQ40059597-09E931AD-FA64-4127-A2A4-BC7EF53AEB2CQ40253383-6C9BAB27-8F5B-40E3-A2C9-315363071E0BQ40896897-34B3360E-C47A-414D-9415-B40933EBED6BQ41991298-6E06C9F8-8EDD-4C94-B5DF-0D134A9478F6Q47195407-F64FC8FF-99AB-4172-B441-D91C3B72F850Q47243124-16D8D16D-5836-40BB-94EE-1E0A0D3E5AF3Q55380454-69B72475-C6B8-4582-BCA8-92F5FA43379B
P2860
Chemokines in tuberculosis: the good, the bad and the ugly.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Chemokines in tuberculosis: the good, the bad and the ugly.
@en
type
label
Chemokines in tuberculosis: the good, the bad and the ugly.
@en
prefLabel
Chemokines in tuberculosis: the good, the bad and the ugly.
@en
P2860
P1476
Chemokines in tuberculosis: the good, the bad and the ugly.
@en
P2093
Leticia Monin
Shabaana A Khader
P2860
P304
P356
10.1016/J.SMIM.2014.09.004
P577
2014-10-22T00:00:00Z